• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用拉普拉斯逆变换分析母体药物静脉注射和口服给药后的代谢物形成药代动力学。

Analysis of metabolite formation pharmacokinetics after intravenous and oral administration of the parent drug using inverse Laplace transformation.

作者信息

Weiss M

机构信息

Section of Pharmacokinetics, Department of Pharmacology, Martin Luther University Halle-Wittenberg, Halle, Germany.

出版信息

Drug Metab Dispos. 1998 Jun;26(6):562-5.

PMID:9616192
Abstract

Models describing the plasma concentration-time curves of generated metabolite after iv and oral drug administration are presented. Utilizing numerical inverse Laplace transformation, the method can readily be used for parameter estimation and model simulation in conjunction with appropriate curve-fitting software. The approach is not limited to compartment modeling and can be applied to any linear pharmacokinetic system exhibiting hepatic and renal elimination of the parent drug. The model is formulated for single and multiple dosing of the precursor, including bolus doses and/or infusions for iv administration and sustained-release dosage forms for oral administration.

摘要

本文展示了描述静脉注射和口服给药后生成代谢物的血浆浓度-时间曲线的模型。利用数值拉普拉斯逆变换,结合适当的曲线拟合软件,该方法可轻松用于参数估计和模型模拟。该方法不限于房室建模,可应用于任何表现出母体药物肝脏和肾脏消除的线性药代动力学系统。该模型适用于前体药物的单次和多次给药,包括静脉注射的推注剂量和/或输注以及口服给药的缓释剂型。

相似文献

1
Analysis of metabolite formation pharmacokinetics after intravenous and oral administration of the parent drug using inverse Laplace transformation.使用拉普拉斯逆变换分析母体药物静脉注射和口服给药后的代谢物形成药代动力学。
Drug Metab Dispos. 1998 Jun;26(6):562-5.
2
The time to reach steady state after the administration of intravenous bolus, constant infusion, and oral immediate-release and sustained-release preparations.静脉推注、持续输注、口服速释和缓释制剂给药后达到稳态的时间。
Pharmacotherapy. 1990;10(6):400-5.
3
Determination of metabolite pharmacokinetics for orally administered prodrugs.口服前体药物代谢物药代动力学的测定。
Drug Metab Dispos. 1987 Jul-Aug;15(4):456-9.
4
Pharmacokinetics and oral bioavailability of pentoxyfylline in broiler chickens.己酮可可碱在肉鸡体内的药代动力学及口服生物利用度
J Vet Pharmacol Ther. 2005 Dec;28(6):575-80. doi: 10.1111/j.1365-2885.2005.00695.x.
5
Pharmacokinetic modelling of pentoxifylline and lisofylline after oral and intravenous administration in mice.己酮可可碱和利索茶碱在小鼠口服及静脉给药后的药代动力学建模
J Pharm Pharmacol. 2007 Apr;59(4):495-501. doi: 10.1211/jpp.59.4.0003.
6
Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after intravenous and oral administration of racemic tramadol.消旋曲马多静脉注射和口服给药后,健康受试者体内曲马多及其主要I期代谢产物的立体选择性药代动力学分析
Biopharm Drug Dispos. 2007 Jan;28(1):19-33. doi: 10.1002/bdd.526.
7
Pharmacokinetics of (-)-epicatechin in rabbits.(-)-表儿茶素在兔体内的药代动力学
Arch Pharm Res. 2009 Jan;32(1):149-54. doi: 10.1007/s12272-009-1129-x. Epub 2009 Jan 29.
8
New models for pharmacokinetic data based on a generalized Weibull distribution.基于广义威布尔分布的药代动力学数据新模型。
J Biopharm Stat. 1999 Mar;9(1):89-107. doi: 10.1081/BIP-100101002.
9
Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.考来烯胺对罗格列酮及其代谢产物去甲基罗格列酮口服和静脉给药后药代动力学的影响:对大鼠口服生物利用度、吸收及代谢处置的作用
Xenobiotica. 2006 Sep;36(9):838-56. doi: 10.1080/00498250600839369.
10
Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.左乙拉西坦静脉输注相对于口服片剂的单剂量生物利用度,以及在健康受试者中左乙拉西坦静脉输注与安慰剂相比的多剂量药代动力学和耐受性。
Clin Ther. 2006 May;28(5):734-44. doi: 10.1016/j.clinthera.2006.05.004.